Breakthrough ‘shrinks’ childhood tumours

OPACC
Aug 13, 2013
1 min read

Cancer Research UK and the University of Southampton have unveiled a therapy for neuroblastoma, an aggressive cancer of the nervous system in infants as young as one year old which can spread to bones, the liver and brain.

Comments

Untreated GHD Linked to Adverse Outcomes in Childhood Cancer Survivors

NCCN Guidelines Now Recommend Naxitamab for High-Risk Neuroblastoma

Common appliance raises kids’ cancer risk nearly twice as much as adults’

How protein-slayer drugs could beat some of the cruellest cancers

Childhood brain tumors develop early in highly specialized nerve cells, research reveals

Pediatric Brain Tumor Risk Increases With CT Radiation Exposure

AI Predicts Pediatric Brain Tumor Relapse With Surprising Accuracy

Study identifies how malaria can lead to childhood cancer

'Phenomenal' - study hailed a significant milestone in child cancer care

FDA Grants Breakthrough Therapy Designation for BrainChild Bio’s B7-H3 CAR T-Cell Therapy for Incurable Pediatric Brain Tumors

Recent Posts